GeneDx

Stamford, United States

GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.

Jan 2023

Post-IPO Equity

Top Investors

BlackRockConnecticut InnovationsOak HC/FTPfizerPerceptive Advisors

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are GeneDx's investors?

GeneDx's investors include BlackRock, Connecticut Innovations, Oak HC/FT, Pfizer, Perceptive Advisors.

Where is GeneDx headquartered?

GeneDx is headquartered in Stamford, United States.

What does GeneDx do?

GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.

What stage is GeneDx at?

GeneDx is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 26, 2023.

MLA

"GeneDx — Funding & Investors." VCBacked, January 26, 2023, https://www.vcbacked.co/company/genedx. Accessed July 1, 2026.

APA

VCBacked. (2023). GeneDx — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/genedx

Wikipedia (cite web)

{{cite web |title=GeneDx — Funding & Investors |url=https://www.vcbacked.co/company/genedx |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 26, 2023.